the orphan drug issue is a result of pharmaceuticals being very much not a free market. consider how absurd it is that you can jack up the price for a product you don't even have a patent for by several thousand percent and still have it be uneconomic for anyone to undercut you. to me, this implies more of an issue with the overall regulatory environment than individual profit-seeking behavior.